Web Exclusives

Thumbnail image for Industry's adoption of natural language processing

Industry's adoption of natural language processing

Adoption of natural language processing and text analytic technologies across healthcare and life science organisations looks set to accelerate with explosive growth in unstructured data and the growing need to gain relevant insight from it.

4th August 2019

Thumbnail image for Getting more from less

Getting more from less

Organisational psychologist Jane Piper on why we should be doing less to achieve more

17th July 2019

Thumbnail image for Taking a wider look at early-stage research

Taking a wider look at early-stage research

The lack of availability of early-stage research, particularly in online repositories, threatens to hinder scientific progress, says Morressier's Sami Benchekroun

5th July 2019

Thumbnail image for Pharma has a case of innovation fatigue - here's how to treat it

Pharma has a case of innovation fatigue - here's how to treat it

The pharma innovation story isn’t resonating with vital stakeholders: prescribers and payers working in healthcare settings. Data from a global study which surveyed decision-makers in the healthcare sector reveals that only 39% of respondents in the UK saw the pharmaceutical industry as innovative.

2nd July 2019

Thumbnail image for Narrowing the provision

Narrowing the provision

The Court of Justice of the European Union (CJEU) has dealt a blow to innovators in two recent significant judgments, addressing questions posed by national courts struggling to judge the eligibility of SPC applications.

25th June 2019

Thumbnail image for The creative health revolution

The creative health revolution

Healthcare communications has always been a bit like Hogwarts. Invisible to most people, massive when you get there, and filled with magic you haven’t yet discovered. There is a creative revolution in healthcare right now.

20th June 2019

Thumbnail image for SmartPeople: Dr Vlado Perkovic

SmartPeople: Dr Vlado Perkovic

Dr Vlado Perkovictalks to PharmaTimes about his hopes for Novo Nordisk’s FLOW trial, and the need to tackle the growing burden of chronic kidney disease (CKD) in the type II diabetes population.

3rd June 2019

Thumbnail image for Are PCSK9 inhibitors about to take off?

Are PCSK9 inhibitors about to take off?

Richa Munjal considers the current landscape for PCSK9 inhibitors and whether there is a brighter future on the horizon for this class of drugs.

27th May 2019

Previous  --   1 2 3 4 5   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download